We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Campaigns to Encourage More AIDS Testing

By Labmedica staff writers
Posted on 14 Dec 2006
OraSure Technologies, Inc. More...
(Bethlehem, PA, USA), a company specializing in oral fluid diagnostics, participated in a special industry panel discussion in observance of World AIDS Day on December 1, 2006. In addition, as part of this commemorative day, OraSure announced the company will actively support a series of campaigns in the United States and in a number of other countries to encourage individuals to learn their human immunodeficiency virus (HIV) status through rapid oral fluid HIV testing.

On both a global and a local level, OraSure supports testing campaigns that will urge people to learn their HIV status. In addition to working with several major cities in the United States, OraSure works with international agencies in a number of countries by providing educational literature and promotional materials along with donated OraQuick AdvanceRapid HIV-1/2 antibody test kits to actively encourage individuals to get tested.

OraSure Technologies supplies oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of HIV. In addition, the company supplies oral-fluid testing solutions for drugs-of-abuse testing.

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products that include immunoassays and other in vitro diagnostic tests, and other medical devices.



Related Links:
OraSure Technologies

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.